Company / PP&E per Share
4D Molecular Therapeutics, Inc. PP&E per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.32
FY2025
5-year range
$0.32 / $0.69
FY2021-FY2025
Trend
-28.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has declined for 3 consecutive years, from $0.69 in FY2022 to $0.32 in FY2025.
Based on SEC 10-K filings.
0.32 in FY2025 with a 5-year CAGR of -19.8%.
Declined from $0.62 to $0.32 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -22.3%
- 5-Year CAGR
- -19.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 4D Molecular Therapeutics, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 28.4% year-over-year.
- Peak pp&e per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.32 | -28.4% |
| FY2024 | $0.45 | -26.5% |
| FY2023 | $0.62 | -10.7% |
| FY2022 | $0.69 | +28.1% |
| FY2021 | $0.54 | -44.9% |
| FY2020 | $0.98 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026